2019 Change % Change Revenue from sales & service 411.58 719.81 -308.23 -42.8% Other income 5.01 5.57 -0.56 -10.1% Total revenue 416.59 725.38 -308.79 -42.6% Cost of goods sold & service 383.13 638.35
% 37.52 55.36 -32.23% Total Revenue 2,101.58 2,164.94 -2.93% 4,298.15 4,270.47 0.65% Cost of hospital operations (1,391.85) (1,483.35) -6.17% (2,906.95) (2,926.87) -0.68% Distribution and Administrative
1,465.51 -535.02 -36.5% Other income 3.28 4.68 -1.60 -34.2% 8.14 9.94 -1.80 -18.1% Total revenue 522.19 750.37 -228.18 -30.4% 938.63 1,475.45 -536.82 -36.4% Cost of goods sold & service 454.43 658.94 -204.51
. Cost of funds for 1Q19 remained stable at 2.3% comparing to 1Q18. For the three-month period ended Consolidated Change Mar 31, 2019 Mar 31, 2018 Baht million % Interest expense 1,386 1,143 242 21.2
for 3Q19 at 7.0% while cost of funds was at 2.4% resulting in loan spread for 3Q19 to decline to 4.6% from 5.1% during 3Q18. For the three-month period ended Consolidated Change Sept 30, 2019 Sept 30
1Q20 to revisit the business plans as well as organizational transformation to drive additional efficiency in order to achieve long-term sustainable cost savings. The implementation of cost control
rates during 1Q20. Interest expense totaled Baht 1,301 million, a decline of 6.1% yoy, with cost of funds declining to 2.0% for 1Q20 comparing to 2.3% for 1Q19 from effective cost management in line with
-Based Products Business, by the Biodiesel Production and Distribution Business saw its performance declined 69% QoQ, mainly from the B100 product price that decreased sharply from the previous quarter. In
million, will give the Company a net cash flow of THB 834.55 million. The Company can use the net cash generated from this transaction as a fund and help reduce financing cost for developing its other